Business / Finance

RSS
Natus Medical second quarter revenue increases 10% to $58.1 million

Natus Medical second quarter revenue increases 10% to $58.1 million

POZEN reports revenue of $4.6 million for second quarter 2011

POZEN reports revenue of $4.6 million for second quarter 2011

TRTB announces supplier contract with Nada Marketing

TRTB announces supplier contract with Nada Marketing

Quality Systems first quarter net revenues increase 21% to $100.4 million

Quality Systems first quarter net revenues increase 21% to $100.4 million

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

Biosign closes brokered private placement for $1,900,000

Biosign closes brokered private placement for $1,900,000

Watson to acquire portfolio of divested generic pharmaceutical products

Watson to acquire portfolio of divested generic pharmaceutical products

BioSante to offer and sell shares of common stock in an underwritten public offering

BioSante to offer and sell shares of common stock in an underwritten public offering

BD to acquire Carmel Pharma

BD to acquire Carmel Pharma

Thermo Fisher Scientific second quarter revenues increase 12% to record $2.90 billion

Thermo Fisher Scientific second quarter revenues increase 12% to record $2.90 billion

CytRx prices underwritten public offering of common stock

CytRx prices underwritten public offering of common stock

Aetna second-quarter operating earnings increase to $522.8 million

Aetna second-quarter operating earnings increase to $522.8 million

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Dow second quarter sales increase to $16.0 billion

Dow second quarter sales increase to $16.0 billion

Teleflex second quarter net revenues increase 9.2% to $391.3 million

Teleflex second quarter net revenues increase 9.2% to $391.3 million

Repligen first quarter total revenue increases 9% to $7,654,000

Repligen first quarter total revenue increases 9% to $7,654,000

Corning second quarter sales increase 17% to $2 billion

Corning second quarter sales increase 17% to $2 billion

DMA announces new name and logo

DMA announces new name and logo

Wolters Kluwer announces divestment of Pharma business

Wolters Kluwer announces divestment of Pharma business

Teva second quarter net sales increase 11% to $4.2 billion

Teva second quarter net sales increase 11% to $4.2 billion

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.